Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Familial lupus anticoagulant.

C Tănăseanu¹, S Tănăseanu

¹Emergency Hospital, SF. Pantelimon, Department of Internal Medicine, Bucharest, Romania.

Roumanian Archives of Microbiology and Immunology

|February 16, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Vascular endothelial growth factor, lipoporotein-associated phospholipase A2, sP-selectin and antiphospholipid antibodies, biological markers with prognostic value in pulmonary hypertension associated with chronic obstructive pulmonary disease and systemic lupus erithematosus.

European journal of medical research·2007

Same author

Clinical particularities in a Romanian series of Behcet's disease patients.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2004

Same author

Limited Wegener's disease presenting as pharyngolaryngeal tumor.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2004

Same author

Significance of platelet-activating factor acetylhydrolase in patients with non-insulin-dependent (type 2) diabetes mellitus.

Journal of cellular and molecular medicine·2003

Same author

Pycnogenol efficacy in the treatment of systemic lupus erythematosus patients.

Phytotherapy research : PTR·2001

Same author

Dysregulation of p56lck kinase in patients with systemic lupus erythematosus.

Autoimmunity·2001

Primary antiphospholipid antibody syndrome (PAPS) involves thrombosis linked to antiphospholipid antibodies (APLA). Familial screening is crucial for preventing thrombotic events in those with APLA, guiding treatment strategies.

Area of Science:

Immunology
Hematology
Genetics

Background:

Antiphospholipid antibody syndrome (APS) is characterized by arterial and venous thromboses and antiphospholipid antibodies (APLA).
Primary APS (PAPS) is considered a relatively homogeneous condition.
Genetic factors, including HLA, may play a role in the pathogenesis of APS.

Observation:

Two patients diagnosed with PAPS (lupus anticoagulant positive) were identified.
Family members of these patients underwent analysis for clinical and laboratory markers associated with APS.
This familial screening aimed to identify individuals at risk within the family structure.

Findings:

Familial screening revealed clinical and laboratory abnormalities related to APS in family members.

Related Experiment Videos

The study highlights the importance of investigating family history in patients with PAPS.

Early identification of at-risk family members can aid in preventative strategies.

Implications:

Familial screening for APS is essential for the early detection and prevention of thrombotic events.
Understanding the familial component of APS can lead to improved risk stratification.
Prophylactic measures, such as low-dose aspirin for asymptomatic individuals with APLA, may be considered.